In PAD patients, pro-inflammatory IL-1β or TNF-α, and endotoxins, are frequently increased as a consequence of the inflammation and infection at the level of the foot, and these cytokines may stimulate SOCS proteins, promoting a GH insensibility. The gene discussed is GH1; the disease is infection.